U.S. Global Investors (USGI)’s Biogen BIIB Stock Holding History

U.S. Global Investors (USGI)’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,000	Closed	-$1.27M	–	305
2015 Q1	$1.27M	Hold	3,000	–	–	0.35%	78
2014 Q4	$1.02M	Sell	3,000 -5,000	-63%	-$1.62M	0.27%	87
2014 Q3	$2.65M	Hold	8,000	–	–	0.75%	52
2014 Q2	$2.52M	Hold	8,000	–	–	0.54%	62
2014 Q1	$2.45M	Sell	8,000 -500	-6%	-$159K	0.4%	89
2013 Q4	$2.38M	Buy	8,500 +4,500	+113%	+$1.16M	0.43%	80
2013 Q3	$963K	Buy	+4,000	New	+$895K	0.16%	120

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

U.S. Global Investors (USGI)'s BIIB Position: Q2 2015 in Review

U.S. Global Investors (USGI) sold out of Biogen (BIIB) in Q2 2015, closing a stake of 3,000 shares — an estimated $1.27M sold.

U.S. Global Investors (USGI) first reported a position in BIIB in Q3 2013 and held it in 7 quarters. The position peaked at $2.65M in Q3 2014. 974 funds tracked by Wall St. Rank hold BIIB as of Q2 2015.

U.S. Global Investors (USGI) reported no remaining Biogen position as of Q2 2015 after selling out during the quarter.
U.S. Global Investors (USGI) sold 3,000 Biogen shares in Q2 2015, an estimated $1.27M.
U.S. Global Investors (USGI) first reported a position in Biogen in Q3 2013 and held it in 7 quarters.
U.S. Global Investors (USGI)'s Biogen position peaked at $2.65M in Q3 2014.
974 funds tracked by Wall St. Rank held Biogen as of Q2 2015.

Based on U.S. Global Investors (USGI)'s 13F filing for Q2 2015, filed 14 Aug 2015.